Login to Your Account

Stick a Replication Fork in It

PARP Inhibitors Target Cohesin-Mutated Cells

By Anette Breindl
Science Editor

Monday, March 19, 2012
Researchers from the University of British Columbia have identified a new set of mutations that make tumor cells vulnerable to Poly(ADP-ribose) polymerase, or PARP, inhibitors. The genes in question, for cohesins, join BRCA and RAD51D as possible biomarkers for tumors that are sensitive to PARP inhibitors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription